Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Lockey

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|October 24, 2012
Adolescents and anaphylaxisRichard Lockey
The Journal of Allergy and Clinical Immunology|June 6, 2003
Oral tacrolimus for severe recalcitrant atopic eczemaBrian Schroer, Richard Lockey
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Sinonasal Disease: An Underappreciated EntityRobert Naclerio, Richard Lockey
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 2, 2011
Pediatric obstructive sleep apnea syndrome (OSAS) for the allergist: update on the assessment and managementMichel Alkhalil, Richard Lockey
The World Allergy Organization Journal|December 27, 2012
Dermatology for the allergistDennis Kim, Richard Lockey
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 5, 2009
Reactions to prick and intradermal skin testsAndrew Bagg, Thomas Chacko, Richard Lockey
Frontiers in Pharmacology|July 13, 2013
New hope for Nutlin-3a therapy for pulmonary arterial hypertensionJutaro Fukumoto, Richard Lockey, Narasaiah Kolliputi
Frontiers in Aging Neuroscience|August 23, 2013
Is isoprenylcysteine carboxyl methyltransferase the key to reverse ageing?Danielle Grams, Richard Lockey, Narasaiah Kolliputi
Expert Opinion on Drug Metabolism & Toxicology|July 22, 2009
Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthmaDennis Kim, Mark Glaum, Richard Lockey
Cell Biochemistry and Biophysics|May 1, 2023
Nuclear Export Inhibitors Selinexor (KPT-330) and Eltanexor (KPT-8602) Provide a Novel Therapy to Reduce Tumor Growth by Induction of PANoptosisSamuel Camilli, Richard Lockey, Narasaiah Kolliputi
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|October 24, 2012
Adolescents and anaphylaxisRichard Lockey
The Journal of Allergy and Clinical Immunology|June 6, 2003
Oral tacrolimus for severe recalcitrant atopic eczemaBrian Schroer, Richard Lockey
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Sinonasal Disease: An Underappreciated EntityRobert Naclerio, Richard Lockey
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 2, 2011
Pediatric obstructive sleep apnea syndrome (OSAS) for the allergist: update on the assessment and managementMichel Alkhalil, Richard Lockey
The World Allergy Organization Journal|December 27, 2012
Dermatology for the allergistDennis Kim, Richard Lockey
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 5, 2009
Reactions to prick and intradermal skin testsAndrew Bagg, Thomas Chacko, Richard Lockey
Frontiers in Pharmacology|July 13, 2013
New hope for Nutlin-3a therapy for pulmonary arterial hypertensionJutaro Fukumoto, Richard Lockey, Narasaiah Kolliputi
Frontiers in Aging Neuroscience|August 23, 2013
Is isoprenylcysteine carboxyl methyltransferase the key to reverse ageing?Danielle Grams, Richard Lockey, Narasaiah Kolliputi
Expert Opinion on Drug Metabolism & Toxicology|July 22, 2009
Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthmaDennis Kim, Mark Glaum, Richard Lockey
Cell Biochemistry and Biophysics|May 1, 2023
Nuclear Export Inhibitors Selinexor (KPT-330) and Eltanexor (KPT-8602) Provide a Novel Therapy to Reduce Tumor Growth by Induction of PANoptosisSamuel Camilli, Richard Lockey, Narasaiah Kolliputi
Pageof 8